Healthcare Shares Split as AVITA, ACL and CSL Lead a Volatile Week

• AVITA Medical rose 26.24% after a study found its wound product cut product costs by 70%.
• Australian Clinical Labs gained 25.96% despite a 0.7% revenue fall and a $332 million goodwill write-down.
• CSL climbed 23.30% even as restructuring charges produced a US$2.6 billion statutory loss.
• Pro Medicus and Dimerix secured major contracts and partnerships, while several smaller companies faced funding pressure.